The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,445,510 in first-year total cost, median $1,326,630.
Most frequent study sections
- Special Emphasis Panel[ZAI1 VS-A (M1)]2
- Special Emphasis Panel[ZAI1 LP-I (M1)]1
- Special Emphasis Panel[ZAI1 SAS-M (M1)]1
- Special Emphasis Panel[ZAI1 TCB-I (M1)]1
Most frequent institutions
- CEDARS-SINAI MEDICAL CENTER1
- DUKE UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF MINNESOTA1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT)1R01AI195133-01 | BAHR, NATHANPASQUALOTTO, ALESSANDRO COMARU | UNIVERSITY OF MINNESOTA, MN | $870,925 | ZAI1 |
| 2024 | Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD1U01AI177195-01A1 | HANSEL, NADIA NPUTCHA, NIRUPAMA | JOHNS HOPKINS UNIVERSITY, MD | $2,520,503 | ZAI1 |
| 2024 | Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation1R01AI184203-01 | HEEGER, PETER SCOTTJORDAN, STAN | CEDARS-SINAI MEDICAL CENTER, CA | $2,216,525 | ZAI1 |
| 2024 | Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST)1R01AI181764-01A1 | LE, THUY | DUKE UNIVERSITY, NC | $1,326,630 | ZAI1 |
| 2024 | Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMV Preventionin D+R- Recipients1R01AI184205-01 | BRENNAN, DANIEL CONLONFISHER, CYNTHIA ELIMAYE, ABHIJIT PRAKASH | UNIVERSITY OF WASHINGTON, WA | $510,927 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.